Serum pigment epithelium-derived factor levels are increased in patients with biopsy-proven nonalcoholic fatty liver disease and independently associated with liver steatosis.

YILMAZ, YUSUF; EREN, FATİH; Ayyildiz, Talat; Colak, Yasar; Kurt, Ramazan; Senates, Ebubekir; Tuncer, Ilyas; Dolar, MAHMUT; Imeryuz, Nese

doi:10.1016/j.cca.2011.08.025

Serum pigment epithelium-derived factor levels are increased in patients with biopsy-proven nonalcoholic fatty liver disease and independently associated with liver steatosis.

Atıf İçin Kopyala

YILMAZ Y., EREN F., Ayyildiz T., Colak Y., Kurt R., Senates E., ...Daha Fazla

Clinica chimica acta; international journal of clinical chemistry, cilt.412, ss.2296-9, 2011 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 412
Basım Tarihi: 2011
Doi Numarası: 10.1016/j.cca.2011.08.025
Dergi Adı: Clinica chimica acta; international journal of clinical chemistry
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.2296-9
Bursa Uludağ Üniversitesi Adresli: Evet

Özet

Background: Increased serum concentrations of pigment epithelium-derived factor (PEDF) have been linked to the metabolic syndrome in the general population. However, the relationship between serum PEDF and nonalcoholic fatty liver disease (NAFLD), a hepatic manifestation of the metabolic syndrome, remains unknown.